Mechanisms of cellular therapy in respiratory diseases
暂无分享,去创建一个
P. Pelosi | P. Rocco | M. Morales | M. Antunes | S. C. Abreu | S. Abreu
[1] K. Tan,et al. Cardiomyocytes from Human Embryonic Stem Cells , 2013 .
[2] Y. Moodley,et al. Cellular therapies for lung disease: A distant horizon , 2011, Respirology.
[3] Xing-hua Chen,et al. Granulocyte-colony stimulating factor-mobilized mesenchymal stem cells: A new resource for rapid engraftment in hematopoietic stem cell transplantation. , 2011, Medical hypotheses.
[4] P. Rocco,et al. Effects of bone marrow-derived mononuclear cells on airway and lung parenchyma remodeling in a murine model of chronic allergic inflammation , 2011, Respiratory Physiology & Neurobiology.
[5] H. Broxmeyer,et al. Adipose stem cell treatment in mice attenuates lung and systemic injury induced by cigarette smoking. , 2011, American journal of respiratory and critical care medicine.
[6] O. Greco,et al. Unicentric study of cell therapy in chronic obstructive pulmonary disease/pulmonary emphysema , 2011, International journal of chronic obstructive pulmonary disease.
[7] A. Liras. Future research and therapeutic applications of human stem cells: general, regulatory, and bioethical aspects , 2010, Journal of Translational Medicine.
[8] M. Matthay,et al. Antibacterial Effect of Human Mesenchymal Stem Cells Is Mediated in Part from Secretion of the Antimicrobial Peptide LL‐37 , 2010, Stem cells.
[9] Arthur S Slutsky,et al. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. , 2010, American journal of respiratory and critical care medicine.
[10] B. Thompson,et al. Therapeutic potential of mesenchymal stem cells for severe acute lung injury. , 2010, Chest.
[11] C. Takiya,et al. Bone marrow-derived mononuclear cell therapy attenuates silica-induced lung fibrosis , 2010, European Respiratory Journal.
[12] C. Takiya,et al. Bone Marrow Mononuclear Cell Therapy Led to Alveolar-Capillary Membrane Repair, Improving Lung Mechanics in Endotoxin-Induced Acute Lung Injury , 2010, Cell transplantation.
[13] Jian-cheng Xu,et al. INTRAVENOUS DELIVERY OF BONE MARROW-DERIVED ENDOTHELIAL PROGENITOR CELLS IMPROVES SURVIVAL AND ATTENUATES LIPOPOLYSACCHARIDE-INDUCED LUNG INJURY IN RATS , 2010, Shock.
[14] P. Pelosi,et al. Bone marrow-derived mononuclear cell therapy in experimental pulmonary and extrapulmonary acute lung injury , 2010, Critical care medicine.
[15] Jae W. Lee,et al. Allogeneic Human Mesenchymal Stem Cells Restore Epithelial Protein Permeability in Cultured Human Alveolar Type II Cells by Secretion of Angiopoietin-1*♦ , 2010, The Journal of Biological Chemistry.
[16] J. Lei,et al. Autocrine production of TGF-beta1 promotes myofibroblastic differentiation of neonatal lung mesenchymal stem cells. , 2010, American journal of physiology. Lung cellular and molecular physiology.
[17] B. Gutfilen,et al. Intrabronchial instillation of bone marrow derived mononuclear cells in silicotic patients: Nuclear medicine analysis and follow-up , 2010, ATS 2010.
[18] M. Mathru. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung , 2010 .
[19] A. Malkinson,et al. Clara cell: progenitor for the bronchiolar epithelium. , 2010, The international journal of biochemistry & cell biology.
[20] B. Gutfilen,et al. Intratracheal instillation of bone marrow-derived cell in an experimental model of silicosis , 2009, Respiratory Physiology & Neurobiology.
[21] B. Stripp,et al. Bronchiolar progenitor cells. , 2009, Proceedings of the American Thoracic Society.
[22] G. Stamp,et al. Bone Marrow Stem Cells Expressing Keratinocyte Growth Factor via an Inducible Lentivirus Protects against Bleomycin-Induced Pulmonary Fibrosis , 2009, PloS one.
[23] P. Lønning,et al. Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. , 2009, Cancer research.
[24] S. Savitz,et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. , 2009, Stem cells and development.
[25] G. Martin,et al. Recent trends in acute lung injury mortality: 1996–2005* , 2009, Critical care medicine.
[26] Leelee Ong,et al. Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy. , 2009, Microvascular research.
[27] M. Burdick,et al. The role of circulating mesenchymal progenitor cells, fibrocytes, in promoting pulmonary fibrosis. , 2009, Transactions of the American Clinical and Climatological Association.
[28] S. Janes,et al. Mesenchymal stem cells as vectors for lung disease. , 2008, Proceedings of the American Thoracic Society.
[29] D. Krause. Bone marrow-derived cells and stem cells in lung repair. , 2008, Proceedings of the American Thoracic Society.
[30] M. Matthay. Treatment of acute lung injury: clinical and experimental studies. , 2008, Proceedings of the American Thoracic Society.
[31] P. Pelosi,et al. Pulmonary and extrapulmonary acute respiratory distress syndrome: myth or reality? , 2008, Current opinion in critical care.
[32] N. Horwood,et al. Potential of mesenchymal stem cell therapy , 2007, Current opinion in oncology.
[33] Giselle Chamberlain,et al. Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for Homing , 2007, Stem cells.
[34] D. Stewart,et al. Competing Interests: This work was , 2022 .
[35] Jae W. Lee,et al. Intrapulmonary Delivery of Bone Marrow-Derived Mesenchymal Stem Cells Improves Survival and Attenuates Endotoxin-Induced Acute Lung Injury in Mice1 , 2007, The Journal of Immunology.
[36] L. Ortiz,et al. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury , 2007, Proceedings of the National Academy of Sciences.
[37] S. Kitamura,et al. Effect of Hypoxia on Gene Expression of Bone Marrow‐Derived Mesenchymal Stem Cells and Mononuclear Cells , 2007, Stem cells.
[38] F. Martinez,et al. Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts. , 2007, The Journal of clinical investigation.
[39] A. Burns,et al. A pure population of lung alveolar epithelial type II cells derived from human embryonic stem cells , 2007, Proceedings of the National Academy of Sciences.
[40] T. Nagayasu,et al. FIBROBLAST GROWTH FACTOR-2 PROMOTES RECOVERY OF PULMONARY FUNCTION IN A CANINE MODELS OF ELASTASE-INDUCED EMPHYSEMA , 2007, Experimental lung research.
[41] John S. Van Arnam,et al. Threshold of Lung Injury Required for the Appearance of Marrow‐Derived Lung Epithelia , 2006, Stem cells.
[42] A. Avogaro,et al. Circulating Progenitor Cells Are Reduced in Patients with Severe Lung Disease , 2006, Stem cells.
[43] M. Moss,et al. Progenitor cells in acute lung injury. , 2006, Minerva anestesiologica.
[44] B. Willis,et al. Epithelial origin of myofibroblasts during fibrosis in the lung. , 2006, Proceedings of the American Thoracic Society.
[45] J. Polak,et al. Derivation of Distal Lung Epithelial Progenitors from Murine Embryonic Stem Cells Using a Novel Three‐Step Differentiation Protocol , 2006, Stem cells.
[46] D. Stewart,et al. Microvascular Regeneration in Established Pulmonary Hypertension by Angiogenic Gene Transfer Materials and Methods Cell Isolation and Culture , 2022 .
[47] P. Palange,et al. Circulating haemopoietic and endothelial progenitor cells are decreased in COPD , 2006, European Respiratory Journal.
[48] V. Peinado,et al. Identification of vascular progenitor cells in pulmonary arteries of patients with chronic obstructive pulmonary disease. , 2006, American journal of respiratory cell and molecular biology.
[49] P. N. Rao,et al. Circulating Progenitor Epithelial Cells Traffic via CXCR4/CXCL12 in Response to Airway Injury1 , 2006, The Journal of Immunology.
[50] A. Trumpp,et al. Bone-marrow haematopoietic-stem-cell niches , 2006, Nature Reviews Immunology.
[51] D. Prockop,et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.
[52] A. Quyyumi,et al. Increased circulating endothelial progenitor cells are associated with survival in acute lung injury. , 2005, American journal of respiratory and critical care medicine.
[53] T. Jacks,et al. Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer , 2005, Cell.
[54] R. Mulligan,et al. Failure of bone marrow to reconstitute lung epithelium. , 2005, American journal of respiratory cell and molecular biology.
[55] M. Rojas,et al. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. , 2005, American journal of respiratory cell and molecular biology.
[56] S. Rennard,et al. Cells derived from the circulation contribute to the repair of lung injury. , 2004, American journal of respiratory and critical care medicine.
[57] H. Kubo,et al. Hepatocyte growth factor induces angiogenesis in injured lungs through mobilizing endothelial progenitor cells. , 2004, Biochemical and biophysical research communications.
[58] S. Dimmeler,et al. Endothelial Progenitor Cells: Characterization and Role in Vascular Biology , 2004, Circulation research.
[59] ToyoakiMurohara,et al. Smoking Cessation Rapidly Increases Circulating Progenitor Cells in Peripheral Blood in Chronic Smokers , 2004 .
[60] S Chunmeng,et al. Effects of plastic-adherent dermal multipotent cells on peripheral blood leukocytes and CFU-GM in rats. , 2004, Transplantation proceedings.
[61] J. Itskovitz‐Eldor,et al. Differentiation of Human Embryonic Stem Cells into Insulin‐Producing Clusters , 2004, Stem cells.
[62] M. Burnett,et al. Marrow-Derived Stromal Cells Express Genes Encoding a Broad Spectrum of Arteriogenic Cytokines and Promote In Vitro and In Vivo Arteriogenesis Through Paracrine Mechanisms , 2004, Circulation research.
[63] S. Phan,et al. Bone marrow-derived progenitor cells in pulmonary fibrosis. , 2004, The Journal of clinical investigation.
[64] N. Anthonisen,et al. Contemporary management of chronic obstructive pulmonary disease: scientific review. , 2003, JAMA.
[65] Naftali Kaminski,et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[66] C. Goss,et al. Incidence of acute lung injury in the United States. , 2003, Critical care medicine.
[67] S. Yamanaka,et al. Role of ERas in promoting tumour-like properties in mouse embryonic stem cells , 2003, Nature.
[68] J. Greenberger,et al. Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis. , 2003, American journal of respiratory cell and molecular biology.
[69] D. Prockop,et al. Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[70] S. Badve,et al. Radiation pneumonitis in mice: a severe injury model for pneumocyte engraftment from bone marrow. , 2002, Experimental hematology.
[71] D. Kotton,et al. Bone marrow-derived cells as progenitors of lung alveolar epithelium. , 2001, Development.
[72] S. Randell,et al. Evidence for stem-cell niches in the tracheal epithelium. , 2001, American journal of respiratory cell and molecular biology.
[73] Neil D. Theise,et al. Multi-Organ, Multi-Lineage Engraftment by a Single Bone Marrow-Derived Stem Cell , 2001, Cell.
[74] Jill Moss,et al. Mesenchymal precursor cells in the blood of normal individuals , 2000, Arthritis Research & Therapy.